← Leaderboards
Mary J Turk
Dartmouth College
$10,495,937
Attributed
$12,968,698
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,968,698 · 10
By mechanism
R01$11,785,727 · 4
P30$467,385 · 4
R21$387,585 · 1
P20$328,001 · 1
Top collaborators
- Randolph J. Noelle5 shared
- Yina Hsing Huang4 shared
Most similar at Dartmouth College
Same institution · by research overlap
- Yina Hsing Huang$9,223,824
- William G North$5,028,670
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsT-LymphocyteImmunotherapyTumorTumor ImmunityImmuneT Memory CellImmunityMelanomaImmune ResponseResponseCellsMemoryCd8b1 GeneNeoplasm MetastasisGenerationsCancer ImmunotherapyCancer PatientMetastatic MelanomaAutoantigensTissuesImmune SystemCancer TherapyImmune Checkpoint Inhibitor
Grant awards (39)
Tissue Resident memory T cell responses to cancer$571,578
R01 · FY2025 · CA · contact PI
Sustaining Tissue Resident Memory T cells$537,503
R01 · FY2025 · CA
Immunology and Cancer Immunotherapy$85,391
P30 · FY2025 · CA · contact PI
Tissue Resident memory T cell responses to cancer$543,000
R01 · FY2024 · CA · contact PI
Sustaining Tissue Resident Memory T cells$510,630
R01 · FY2024 · CA
Immunology and Cancer Immunotherapy (ICI)$61,336
P30 · FY2024 · CA · contact PI
Immunology and Cancer Immunotherapy (ICI)$5,263
P30 · FY2024 · CA · contact PI
Tissue Resident memory T cell responses to cancer$585,816
R01 · FY2023 · CA · contact PI
Sustaining Tissue Resident Memory T cells$526,754
R01 · FY2023 · CA
Immunology and Cancer Immunotherapy (ICI)$61,338
P30 · FY2023 · CA · contact PI
Sustaining Tissue Resident Memory T cells$537,503
R01 · FY2022 · CA
Tissue Resident memory T cell responses to cancer$522,276
R01 · FY2022 · CA · contact PI
Immunology and Cancer Immunotherapy (ICI)$61,338
P30 · FY2022 · CA · contact PI
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors$570,047
R01 · FY2021 · CA
Tissue Resident memory T cell responses to cancer$532,934
R01 · FY2021 · CA · contact PI
Immunology and Cancer Immunotherapy (ICI)$61,338
P30 · FY2021 · CA · contact PI
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors$570,047
R01 · FY2020 · CA
Tissue Resident memory T cell responses to cancer$532,934
R01 · FY2020 · CA · contact PI
Immunology and Cancer Immunotherapy (ICI)$61,338
P30 · FY2020 · CA · contact PI
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors$552,945
R01 · FY2019 · CA
Tissue Resident memory T cell responses to cancer$516,944
R01 · FY2019 · CA · contact PI
Immunology & Cancer Immunotherapy (ICI)$70,043
P30 · FY2019 · CA · contact PI
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors$570,047
R01 · FY2018 · CA
Tissue Resident memory T cell responses to cancer$530,226
R01 · FY2018 · CA · contact PI
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors$570,047
R01 · FY2017 · CA
Immunological manipulation of resistance to molecularly targeted inhibitors$211,410
R21 · FY2017 · CA · contact PI
Mechanisms of concomitant tumor immunity and autoimmunity$279,212
R01 · FY2016 · CA · contact PI
Immunological manipulation of resistance to molecularly targeted inhibitors$176,175
R21 · FY2016 · CA · contact PI
Mechanisms of concomitant tumor immunity and autoimmunity$214,993
R01 · FY2015 · CA · contact PI
Mechanisms of concomitant tumor immunity and autoimmunity$208,544
R01 · FY2014 · CA · contact PI
Mechanisms of concomitant tumor immunity and autoimmunity$201,886
R01 · FY2013 · CA · contact PI
Mechanisms of concomitant tumor immunity and autoimmunity$213,666
R01 · FY2012 · CA · contact PI
Mechanisms of Concomitant Tumor Immunity$275,593
R01 · FY2010 · CA · contact PI
Mechanisms of Concomitant Tumor Immunity$275,593
R01 · FY2009 · CA · contact PI
Mechanisms of Concomitant Tumor Immunity$275,593
R01 · FY2008 · CA · contact PI
Mechanisms of Concomitant Tumor Immunity$275,593
R01 · FY2007 · CA · contact PI
Mechanisms of Concomitant Tumor Immunity$283,823
R01 · FY2006 · CA · contact PI
COBRE: DMS: MECHANISMS OF CONCOMITANT TUMOR IMMUNITY$215,026
P20 · FY2006 · RR · contact PI
COBRE: DMS: MECHANISMS OF CONCOMITANT TUMOR IMMUNITY$112,975
P20 · FY2005 · RR